The CHS Board of Directors is a skills-based board meaning it is composed of individual skills, expertise, qualifications and personal characteristics. In 2023, multiple Board...
by James Bayford – Kelowna, British Columbia “Why?” Is a question I asked myself as I laced up my running shoes before a scheduled 20...
CLICK HERE to access the periodic review of novel treatments in hemophilia and other bleeding disorders by the European Haemophilia Consortium.
This past summer, the Canadian Hemophilia Society (CHS) conducted an on-line survey on attitudes to and knowledge about gene therapy. The results were presented and...
Héma-Québec announced on November 30, following its Request for Proposals for recombinant factor VIII concentrates, that it had selected Esperoct. Esperoct is approved by Health...
Last August, the European Medicines Agency (EMA) granted conditional marketing authorization to BioMarin’s Roctavian (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A...
Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene...
Each year the CHS honours individuals who have made a significant contribution to improving the quality of life of people with bleeding disorders. The 2023...
HIV Justice News published the following on October 28: “The past two weeks has seen some important HIV Justice advances in three countries – Canada,...
The tainted blood tragedy is incontestably the worst public health disaster that Canada has ever faced. Today, October 27, anniversary of the creation of the...
by Zander Masser, Montreal, QC On a fall day in 1996, my parents called a family meeting. I was 11 years old. My brother was...
The CHS is hiring a National Community Programs Manager. We would greatly appreciate it if you could share this career opportunity with your network. Thank...
The CHS is announcing its Call for Applications for its research programs for the 2023-2024 grant period. The deadline to submit applications for all the...
Montreal, September 7, 2022 – “The Canadian Hemophilia Society (CHS) strongly supports Canadian Blood Services’ plans to work with a leading company in the plasma...